Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit.
The effects of pharmacologic doses of gonadotropin-releasing hormone, danazol, and indomethacin on the clinical and endocrinologic features of the ovarian hyperstimulation syndrome were studied in the rabbit. The ovarian hyperstimulation syndrome was induced with Pergonal (75 IU of follicle-stimulating hormone and 75 IU of luteinizing hormone) and a follicle-stimulating hormone-dominant gonadotropin preparation (85 IU of follicle-stimulating hormone and 53 IU of luteinizing hormone). None of the three agents tested were effective in suppressing the ovarian enlargement and ascites formation in these animals. Ascites developed despite quite significant variations in plasma and intraovarian sex steroid hormone and intraovarian prostaglandin F levels induced by danazol and indomethacin. Ascites develops in hyperstimulated women in association with both follicular and luteal hyperstimulation. In contrast, the ascites response in the hyperstimulated rabbit develops in the presence of follicular hyperstimulation alone without a significant degree of luteal hyperstimulation.
D000818:Animals; D001201:Ascites / Q000517:prevention & control; D003613:Danazol / Q000494:pharmacology*; D005260:Female; D005640:Follicle Stimulating Hormone; D007213:Indomethacin / Q000494:pharmacology*; D007986:Luteinizing Hormone; D008596:Menotropins; D010049:Ovarian Diseases / Q000139:chemically induced* / Q000517:prevention & control; D006080:Ovarian Follicle / Q000187:drug effects; D010053:Ovary / Q000187:drug effects*; D010062:Ovulation Induction; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology*; D011245:Pregnadienes / Q000494:pharmacology*; D011817:Rabbits; D013577:Syndrome
D010906:Pituitary Hormone-Releasing Hormones; D011245:Pregnadienes; D008596:Menotropins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003613:Danazol; D007213:Indomethacin